Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Restructuring Costs (2022)

Cardio Diagnostics Holdings' Restructuring Costs history spans 1 years, with the latest figure at $55034.0 for Q2 2022.

  • For Q2 2022, Restructuring Costs changed N/A year-over-year to $55034.0; the TTM value through Mar 2023 reached $55034.0, changed N/A, while the annual FY2022 figure was $112534.0, N/A changed from the prior year.
  • Restructuring Costs for Q2 2022 was $55034.0 at Cardio Diagnostics Holdings, down from $57500.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $57500.0 in Q1 2022 and bottomed at $55034.0 in Q2 2022.